News

MAST is pleased to announce that it has been awarded the Public Health England (PHE) tender for the exclusive supply of Treponema pallidum particle agglutination assays (TPPA).

Mast is pleased to announce it has been awarded the Public Health England (PHE) tender for the exclusive supply of antibiotic susceptibility (AST) and AMR discs.

MAST^®ALEX-MRSA (RST501); for the detection of penicillin binding protein 2’ (PBP2’) and confirmation of Methicillin resistant Staphylococcus aureus (MRSA)

CRYOBANK^® is based on a cryovial system comprising chemically treated beads immersed in a special cryogenic preserving solution.

COVID-19 Update

Mast is pleased to announce the launch of NEW additions to the MASTDISCS^® AST range for EUCAST and CLSI methodology:

Mast Group Ltd. are pleased to announce the expansion of their molecular product portfolio with the launch of the New MAST ISOPLEX^® CRE-ART  kit for the rapid molecular detection of carbapenemase producing organisms (CPOs).

Mast are pleased to announce the launch of the NEW  MASTDISCS^® Combi  ESBL Detection Set (EUCAST) with the new disc potencies as recommended by EUCAST for the reliable detection of ESBL producing Enterobacterales.

MAST^® ASSURE Bacterial Agglutinating Antisera products are a comprehensive range of polyvalent and monovalent diagnostic antisera for bacterial identification.

Mast Group Ltd. exhibited at the Institute of Biomedical Science Congress 2019 at the International Convention Centre in Birmingham 22^nd – 25^th September 2019, and it proved to be a triumph!